Trial Profile
Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome 2017
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2019
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Severe fever with thrombocytopenia syndrome
- Focus Therapeutic Use
- 10 Mar 2019 Status changed from recruiting to completed.
- 11 Mar 2018 Status changed from not yet recruiting to recruiting.
- 13 Sep 2017 New trial record